Clinical Trial Update: Maintenance Bevacizumab Only or Bevacizumab Plus Metronomic Chemotherapy in Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 study comparing maintenance bevacizumab alone versus bevacizumab with metronomic chemotherapy in metastatic colorectal cancer; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (Avastin) (bevacizumab)

Snippet

Sponsor: Azienda Ospedaliero, Universitaria Pisana | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED